Frequently Asked Questions
The market is segmented based on , By Therapeutic Categories (Antinematodal, Anticestodal, Antilung Worm, Antifilarial, Antiprotozoal, Insecticide), Treatment (Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Antiparasitics Drugs Market size was valued at USD 24.00 USD Billion in 2022.
The Global Antiparasitics Drugs Market is projected to grow at a CAGR of 6% during the forecast period of 2023 to 2030.
The major players operating in the market include Pfizer , F. Hoffmann, La Roche Ltd, Mylan N.V., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Novartis AG, Teva Pharmaceutical Industries , Bristol Myers Squibb Company, GSK Plc., Bayer AG, Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim International Gmbh, Sanofi, Arbor Pharmaceuticals , Alkem Labs Ltd.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
